See the DrugPatentWatch profile for Iopamidol
Iopamidol Angiography FDA Label Information
The U.S. Food and Drug Administration (FDA) label for iopamidol, an iodinated contrast agent used in angiography, details its approved uses, administration, warnings, precautions, and adverse reactions. It is indicated for adult and pediatric patients for visualization of blood vessels in computed tomography (CT) and for various angiographic procedures.
What is Iopamidol Used For in Angiography?
Iopamidol is utilized in several diagnostic imaging procedures. These include:
* Cerebral angiography: To visualize blood vessels in the brain.
* Coronary angiography: To examine the arteries supplying the heart muscle.
* Peripheral angiography: To visualize blood vessels in the limbs.
* Abdominal angiography: To assess blood flow in abdominal organs and vessels.
* Computed Tomography (CT) angiography: To enhance visualization of blood vessels in various parts of the body during CT scans [1].
How is Iopamidol Administered for Angiography?
Iopamidol is administered intravenously. The specific dose, injection rate, and volume depend on the type of angiographic procedure, the patient's age, weight, kidney function, and overall clinical condition. The label provides detailed recommendations for each type of examination [1].
What are the Key Warnings and Precautions for Iopamidol?
Patients receiving iopamidol require careful consideration of several risks:
* Risk of Hypersensitivity Reactions: Severe and potentially fatal hypersensitivity reactions, including anaphylaxis, can occur. Patients with a history of previous reactions to iodinated contrast media or those with asthma are at increased risk. Facilities should be equipped to manage these reactions, and appropriate emergency equipment must be readily available [1].
* Risk of Nephropathy: Acute kidney injury (AKI) can occur after administration of iodinated contrast media. Patients with pre-existing renal impairment, diabetes, dehydration, or those receiving certain medications are at higher risk. Maintaining adequate hydration and avoiding nephrotoxic agents around the time of contrast administration are crucial [1].
* Cardiovascular Effects: Transient cardiovascular changes, such as blood pressure fluctuations and heart rate alterations, can occur. Careful monitoring is necessary, especially in patients with cardiovascular disease [1].
* Extravasation: Leakage of the contrast medium into surrounding tissues can cause pain, swelling, and potentially tissue damage. Prompt management is required if extravasation occurs [1].
* Thyroid Storm: Caution is advised in patients with hyperthyroidism or latent hyperthyroidism, as the iodine load from contrast media can precipitate a thyroid storm [1].
What Adverse Reactions Have Been Reported with Iopamidol?
Common adverse reactions associated with iopamidol administration include:
* Nausea
* Vomiting
* Headache
* Dizziness
* Warm sensation
* Pain and swelling at the injection site [1].
Less common but more serious adverse reactions can include severe hypersensitivity reactions, myocardial infarction, stroke, and renal impairment [1].
Can Iopamidol Be Used in Patients with Kidney Problems?
The use of iopamidol in patients with impaired kidney function requires careful evaluation. While it can be used, there is an increased risk of nephropathy. Patients with pre-existing renal disease should be well-hydrated, and any potentially nephrotoxic medications should be discontinued prior to administration. Dose adjustments may be necessary depending on the severity of renal impairment [1].
What is the Difference Between Iopamidol and Other Contrast Agents?
Iopamidol is a non-ionic, low-osmolar contrast medium. Non-ionic contrast agents generally cause fewer adverse reactions, such as pain and heat sensation, compared to ionic contrast media, which are higher-osmolar. This is attributed to their chemical structure, which results in lower osmolality and fewer free ions in solution [1].
Where Can I Find the Official FDA Label for Iopamidol?
The official FDA label for iopamidol can be accessed through the FDA's official drug labeling database. Information on drug approvals, including prescribing information, is available on the FDA website. For a comprehensive understanding of drug patents and market exclusivity, resources like DrugPatentWatch.com can provide detailed analysis [2].
Sources:
[1] Iopamidol Prescribing Information
[2] DrugPatentWatch.com